The hospital discharges for carcinoma in situ in Turkey have shown consistent growth from 2013 to 2023, reaching a value of 9.13 thousand in 2023. Over the last decade, there has been a notable increase with a significant spike in 2015 and a gradual stabilization in the growth rate post-2018. Year-on-year variations indicate fluctuating trends with a peak in 2015 (46.85%) and a steady decline in growth percentages thereafter. The last two years (2022-2023) show a modest growth rate of 3.59%, while the latest five-year CAGR stands at 4.41%.
Forecasted data for 2024-2028 projects a continued upward trajectory, albeit at a slower pace, with a forecasted CAGR of 2.38% and an overall growth rate of 12.5% by 2028. This suggests sustained demand for hospital services for carcinoma in situ, yet with a decelerating growth trend.
Future trends to watch for include advancements in early detection and treatment methods, which could impact discharge rates. Additionally, healthcare policy changes and improvements in preventive care may influence future data.
